先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01302 先健科技

午间休市 05-26 12:05:00

1.860

-0.450

-19.48%

最高2.380	最低1.850	成交量1.64亿
今开2.350	昨收2.310	日振幅22.94%
总市值86.16亿	流通市值86.16亿	总股本46.32亿
成交额3.42亿	换手率3.54%	流通股本46.32亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01302","market":"HK","secType":"STK","nameCN":"先健科技","latestPrice":1.86,"timestamp":1779768300003,"preClose":2.31,"halted":0,"volume":164150000,"delay":0,"changeRate":-0.1948051948051948,"floatShares":4632000000,"shares":4632000000,"eps":0.03809971559079548,"marketStatus":"午间休市","change":-0.45,"latestTime":"05-26 12:05:00","open":2.35,"high":2.38,"low":1.85,"amount":341859952,"amplitude":0.229437,"askPrice":1.87,"askSize":144000,"bidPrice":1.85,"bidSize":258000,"shortable":3,"etf":0,"ttmEps":0.03809971559079548,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779771600000},"marketStatusCode":3,"adr":0,"listingDate":1320854400000,"exchange":"SEHK","adjPreClose":2.31,"openAndCloseTimeList":[[1779759000000,1779768000000],[1779771600000,1779782400000]],"volumeRatio":9.168435,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01302/wiki","defaultTab":"wiki","newsList":[{"id":"2638562912","title":"港股异动 | 先健科技(01302)跌超15% 拟18.7亿元收购华医圣杰96.46%股权 以可换股债券支付代价","url":"https://stock-news.laohu8.com/highlight/detail?id=2638562912","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638562912?lang=zh_cn&edition=full","pubTime":"2026-05-26 11:00","pubTimestamp":1779764421,"startTime":"0","endTime":"0","summary":"消息面上，5月22日晚，先健科技发布公告称，拟以代价约18.733亿元向高瓴资本全资持有之AUT-VII收购国内先心封堵器厂商华医圣杰约96.46%股权，代价全部以发行可换股债券支付，双方并订立具法律约束力的框架协议。公告指出，可换股债券按年利率3.5%计息，每季以现金支付，为期3年，初始转换价为每股2.5港元，比5月22日收报2.31港元溢价约8.2%，悉数行使涉发行约8.6亿股新股，占扩大后股本约15.66%，将令高瓴成为先健科技的单一最大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNDW","VXUS","BK4585","01302","BK1583","BK1100","BK1600","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638660845","title":"先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638660845","media":"新浪港股","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638660845?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:52","pubTimestamp":1779756720,"startTime":"0","endTime":"0","summary":"　　先健科技发布公告，于2026年5月22日，公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司（华医）约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后，华医将成为公司的非全资附属公司，其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为，收购华医符合集团的整体发展策略，并将为公司带来长远的裨益。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-26/doc-inhzequs2977158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","01302","BK1600","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637308535","title":"先健科技拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637308535","media":"新浪港股","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637308535?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:27","pubTimestamp":1779611220,"startTime":"0","endTime":"0","summary":"　　先健科技发布公告，于2026年5月22日，公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司（华医）约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后，华医将成为公司的非全资附属公司，其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为，收购华医符合集团的整体发展策略，并将为公司带来长远的裨益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-24/doc-inhyytnk3397355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","01302","BK1583","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193455178","title":"先健科技拟通过可转债收购思达医疗科技96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1193455178","media":"投资观察","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193455178?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:27","pubTimestamp":1779463664,"startTime":"0","endTime":"0","summary":"先健科技公司（股票代码：1302.HK）宣布，计划通过发行可转换债券的方式，收购思达医疗科技公司96.46%的股权。此项交易旨在进一步整合医疗技术资源，拓展公司在相关领域的业务布局。市场分析人士指出，此次收购若顺利完成，或将增强先健科技在医疗器械细分市场的竞争力，并为其带来新的增长动力。具体交易条款及后续进展有待公司进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01302","BK1600","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637034335","title":"先健科技(01302)拟18.733亿元收购北京华医圣杰科技约96.46%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2637034335","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637034335?lang=zh_cn&edition=full","pubTime":"2026-05-22 23:11","pubTimestamp":1779462692,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先健科技 发布公告，于2026年5月22日，公司拟向卖方AUT-VII HK Holdings Limited收购北京华医圣杰科技有限公司(华医)约96.46%股权。交易代价约为人民币18.733亿元。代价将由公司向卖方发行可换股债券予以支付。交割后，华医将成为公司的非全资附属公司，其财务业绩将并入集团的综合财务报表。华医的产品主要用于治疗先天性心脏缺损及预防心因性栓塞性中风。董事认为，收购华医符合集团的整体发展策略，并将为公司带来长远的裨益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先健科技(01302)拟18.733亿元收购北京华医圣杰科技约96.46%股权","news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01302","BK1583","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637214348","title":"先健科技(01302)：刘剑雄辞任执行董事及公司授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2637214348","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637214348?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:57","pubTimestamp":1779461866,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先健科技(01302)发布公告，刘剑雄先生提呈辞任执行董事及公司授权代表的职务。冯小玲女士提呈辞任执行董事及董事会提名委员会成员的职务，以便彼等各自可将更多时间投入其他事务。经董事会批准，上述辞任将在于2026年5月22日召开的董事会会议上审议后立即生效。于上述辞任后，刘剑雄先生及冯小玲女士各自将继续以彼之其他现有角色及职责服务公司，即：刘剑雄先生将继续担任公司常务副总裁、首席财务官兼公司秘书;冯小玲女士将继续担任公司国际事业部副总裁。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1583","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175970997","title":"先健科技4月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1175970997","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175970997?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:41","pubTimestamp":1778143307,"startTime":"0","endTime":"0","summary":"先健科技于2026年5月7日披露截至2026年4月30日的股份变动月报表。报告显示，公司注册股本数量依旧为40,000,000,000股，每股面值USD 0.00000125，注册股本总额USD 50,000；已发行股本方面，截至2026年4月30日，公司普通股数量为4,631,712,400股，与上月底保持一致。月报显示，当月公司并未新增发行股份、购回股份或注销股份，亦没有产生任何库存股份变动。本次公告经公司秘书刘剑雄签署。根据本次月报披露信息，截至2026年4月30日，先健科技整体股本保持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1144915415","title":"先健科技拟回购最多一成股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1144915415","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144915415?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:39","pubTimestamp":1778056752,"startTime":"0","endTime":"0","summary":"先健科技公司，于香港联合交易所有限公司主板上市，近日在董事会报告中公布了一项股份购回计划。该公司拟于股东周年大会上授予董事一般及无条件授权，可自决议通过之日起至下届股东周年大会结束、或公司章程规定的最后期限届满、或股东在股东大会上通过撤销或修订授权的普通决议日期孰先为止，回购不超过当日公司已发行股本10%的股份或可转换为股份的证券。根据公告，先健科技目前发行股本合计4,631,712,400股，意味最多可购回4.63亿股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先健科技拟回购最多一成股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629087757","title":"【券商聚焦】中信建投：医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为，医疗器械板块拐点已经来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06826","BK1584","BK1100","01302","02190","BK1583","BK1571","BK1501","02235","02252","00241","BK1589","09996","BK1587","LU0173614495.USD","LU0287142896.SGD","BK1222","BK1617","09997","BK1610","BK1574","BK1615","BK1142","BK1502","159883","BK1247","01066","BK1593","BK1600","00853","BK0276","BK1585","601066","BK1591","BK1515","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627541123","title":"【券商聚焦】华安证券维持先健科技(01302)“买入”评级 指其外周业务驱动增长并切入电生理新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2627541123","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627541123?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:19","pubTimestamp":1776158371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华安证券发布研报指，先健科技 2025年经调整后利润表现强劲，核心外周业务驱动增长，并通过战略投资切入电生理新赛道。报告维持对公司的“买入”评级。结构性心脏病业务收入为5.12亿元，同比微降3.0%。此外，公司完成对剑虎医疗第一阶段1亿元投资，获得其22.22%股权及电生理相关产品的独家优先合作权与海外独家经销权，正式战略切入电生理赛道，有望构筑新的长期增长点。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1978933","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","600909"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116016146","title":"先健科技3月未有新增股份发行 股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1116016146","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116016146?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:31","pubTimestamp":1775637072,"startTime":"0","endTime":"0","summary":"先健科技公司于2026年4月8日发布截至2026年3月31日的股份变动月报表。报告显示，公司注册股本维持在40,000,000,000股，总额50,000美元，且已发行股份数量连续两个月保持在4,631,712,400股。报告期内，先健科技无新增股份发行、购回或注销，也无库存股变动。公司当月股份期权方面，共有350,000份期权失效，未有因行使期权而增发股份，至月末两项购股权计划下的剩余期权合计约308,818,750份，可行使数量保持稳定。该公告由公司秘书刘剑雄签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103414290","title":"异动解读 | 先健科技盘中大涨5.49%，因出现大手买入","url":"https://stock-news.laohu8.com/highlight/detail?id=1103414290","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103414290?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:03","pubTimestamp":1775635437,"startTime":"0","endTime":"0","summary":"先健科技(01302)今日盘中大涨5.49%，引起了市场的关注。消息面上，该股在下午交易时段出现大手买入，成交量为140万股，成交价为1.87港元，涉及资金261.8万港元。这种大额买入通常表明有机构投资者或大资金对该公司感兴趣，可能会推动股价上涨。在今日交易中，该股最高价为1.88港元，最低价为1.81港元，总成交量为2503万股，总成交金额为4629万港元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114570195","title":"异动解读 | 先健科技盘中大涨5.36%，业绩利好提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1114570195","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114570195?lang=zh_cn&edition=full","pubTime":"2026-04-01 10:39","pubTimestamp":1775011190,"startTime":"0","endTime":"0","summary":"先健科技（01302）今日盘中股价大幅上涨5.36%，引起了市场的广泛关注。消息面上，公司发布了2025财年业绩公告，显示整体营收保持稳健增长，经调整后的净利润同比大幅提升24.9%，展现出强劲的盈利动能。医疗器械核心业务板块表现突出，创新产品线的市场渗透率持续提升，为利润增长提供了重要支撑。财务数据显示，公司现金流状况保持健康，研发投入占比维持在行业领先水平。管理层表示，未来将继续聚焦心血管介入器械领域的创新突破，并通过全球化布局进一步拓展市场空间。这些积极的业绩表现和未来展望，显著增强了投资者信心，从而推动了股价在交易时段内的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128499417","title":"先健科技公布2025年度业绩：营收稳健增长，调整后净利润跃升24.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128499417","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128499417?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:41","pubTimestamp":1774975275,"startTime":"0","endTime":"0","summary":"先健科技（股票代码：01302）近日发布2025财年业绩公告，公司整体营收保持稳健增长态势。值得关注的是，经调整后的净利润同比大幅提升24.9%，展现出强劲的盈利动能。\n在复杂多变的市场环境中，公司通过优化产品结构和提升运营效率，实现了高质量增长。医疗器械核心业务板块表现突出，创新产品线的市场渗透率持续提升，为利润增长提供重要支撑。\n财务数据显示，公司现金流状况保持健康，研发投入占比维持在行业领先水平。管理层表示，未来将继续聚焦心血管介入器械领域的创新突破，通过全球化布局进一步拓展市场空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1600","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623337710","title":"先健科技(01302.HK)2025年度业绩：经调整纯利大增24.9%  在手现金超7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623337710","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623337710?lang=zh_cn&edition=full","pubTime":"2026-03-31 12:57","pubTimestamp":1774933021,"startTime":"0","endTime":"0","summary":"格隆汇3月31日丨先健科技公布年度业绩，2025年度，集团实现收益约人民币13.698亿元，同比增长约5.1%，其中外周血管病业务贡献的营业额约人民币8.446亿元，同比增长约12.4%。年度毛利约人民币10.191亿元；经调整纯利约人民币3.534亿元，同比增长24.9%。于2025年12月31日，集团的现金及现金等价物约为人民币7.193亿元，较2024年12月31日的约人民币6.658亿元增加约8.0%。　　公告称，中国内地仍是集团最大的市场，截至2025年12月31日止年度，占总收益约71.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260331/32115240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","BK1600","01302","BK1100"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1193751507","title":"先健科技2025年收入增长至13.70亿元，除税前溢利降幅收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1193751507","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193751507?lang=zh_cn&edition=full","pubTime":"2026-03-31 12:34","pubTimestamp":1774931691,"startTime":"0","endTime":"0","summary":"先健科技于2025年度实现收入人民币13.70亿元，较2024年度的人民币13.04亿元上升约5.1%。本公司拥有人应占纯利为人民币1.48亿元，较2024年度的人民币2.22亿元降幅约33.5%。除税前溢利从2024年度的人民币1.99亿元降至2025年度的人民币1.91亿元，所得税开支相应增加至人民币0.79亿元，主要源于先健深圳向其母公司分配溢利产生的税项。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623372703","title":"先健科技(01302)发布年度业绩 股东应占溢利1.48亿元 同比减少33.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623372703","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623372703?lang=zh_cn&edition=full","pubTime":"2026-03-31 12:31","pubTimestamp":1774931471,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先健科技(01302)发布截至2025年12月31日止年度业绩，收益13.7亿元(人民币，下同)，同比增加约5.1%;股东应占溢利1.48亿元，同比减少33.53%;每股基本盈利3.4分。公告称，收益增加主要归因于覆膜支架销售的收益增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1583","01302","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投：医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622818008?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1593","BK1583","01302","159883","BK1247","BK1501","02235","02252","BK1502","BK1585","BK1591","BK0276","601066","BK1161","00853","BK1589","09996","BK1587","BK1574","LU0173614495.USD","BK1615","02190","01066","BK1189","09997","BK1100","BK1571","BK1610","BK1515","00241","BK1222","BK1617","LU0287142896.SGD","BK1600","BK1142","BK1584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618138631","title":"先健科技(01302.HK)拟3月31日举行董事会会议批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138631","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138631?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:57","pubTimestamp":1773309423,"startTime":"0","endTime":"0","summary":"格隆汇3月12日丨先健科技(01302.HK)公布，将于2026年3月31日(星期二)举行董事会会议，并于会上商讨下列事项：1)考虑及批准集团截至2025年12月31日止的经审核的年度业绩，并批准将于联交所及公司网站刊登的该经审核的集团年度业绩公布稿本；2)考虑建议的末期股息(如有)；3)考虑暂停办理公司股份过户登记手续(倘有需要)；4)考虑公司即将举行的股东周年大会的日期、时间及地点；及5)处理任何其他事项(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260312/32063735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01302","BK1583","BK1100","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618990289","title":"先健科技03月10日主力净流出175.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618990289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618990289?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:15","pubTimestamp":1773130559,"startTime":"0","endTime":"0","summary":"03月10日，先健科技股价收平报1.72元，成交金额1840.4万元，换手率0.23%，振幅2.33%，量比0.77。先健科技今日主力资金净流出175.1万元，上一交易日主力净流入378.0万元。该股近5个交易日上涨8.86%，主力资金累计净流入552.5万元；近20日主力资金累计净流出3235.0万元，其中净流出天数为11日。该股主力净额占比0.02%，港股市场排名2557/2721。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310162114a45dec2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310162114a45dec2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01302","BK1600","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lifetechmed.com","stockEarnings":[{"period":"1week","weight":0.1106},{"period":"1month","weight":0.2031},{"period":"3month","weight":0.3588},{"period":"6month","weight":0.2486},{"period":"1year","weight":0.4808},{"period":"ytd","weight":0.4808}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0153},{"period":"1year","weight":0.0876},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先健科技公司是一家主要从事开发、制造及买卖心血管及外周血管疾病及紊乱所用微创介入医疗器械的投资控股公司。该公司主要通过三个分部运营其业务。结构性心脏病业务分部从事买卖、制造及研发与结构性心脏病有关的器械。外周血管病业务分部从事买卖、制造及研发与外周血管病有关的器械。起搏电生理业务分部从事买卖、制造及研发与起搏电生理有关的器械。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.025079},{"month":2,"riseRate":0.384615,"avgChangeRate":0.028221},{"month":3,"riseRate":0.615385,"avgChangeRate":0.017514},{"month":4,"riseRate":0.538462,"avgChangeRate":0.025302},{"month":5,"riseRate":0.615385,"avgChangeRate":0.095595},{"month":6,"riseRate":0.583333,"avgChangeRate":0.059054},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.066814},{"month":8,"riseRate":0.25,"avgChangeRate":-0.049509},{"month":9,"riseRate":0.583333,"avgChangeRate":0.031147},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004062},{"month":11,"riseRate":0.416667,"avgChangeRate":0.043537},{"month":12,"riseRate":0.384615,"avgChangeRate":0.000564}],"exchange":"SEHK","name":"先健科技","nameEN":"LIFETECH SCI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先健科技,01302,先健科技股票,先健科技股票老虎,先健科技股票老虎国际,先健科技行情,先健科技股票行情,先健科技股价,先健科技股市,先健科技股票价格,先健科技股票交易,先健科技股票购买,先健科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先健科技(01302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先健科技(01302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}